Latest Press Releases
View all
TimeHeadline
12m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
39m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
39m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
39m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
40m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Amphastar P logo

Amphastar P

About

Amphastar P (NASDAQ:AMPH) — investor relations, events, news, and company updates on 6ix.

Latest News

Feb 26 2026
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025
Feb 24 2026
Amphastar Announces FDA Approval for Ipratropium Bromide HFA
Feb 20 2026
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
Jan 12 2026
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
Jan 7 2026
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

Financials

Revenue
$719.89 M
Market Cap
$939.72 M
P/E Ratio
10.07
EPS
2.03

Community Chat

Ask AI

6ix6ixAIEvents